Furthermore, the pathways related to cancer and HIF-1 signaling, although having less direct connection with diabetes, may exert anti-inflammatory or antioxidant effects through common targets such as NFKB1 [23]. The gene discussed is NFKB1; the disease is diabetes mellitus.